Vaccine stands for a preparation of dead, attenuate or else modified viruses, bacteria and other microorganisms utilized as an inoculation to immunize against any disease by way of stimulating antibodies’ production. With constant technology upgrades and launches of new medicinal products, Vaccines proved to be the most sophisticated healthcare aid ever created in the pharma’s history.
The global Vaccine Industry is thriving mainly owing to the chronic availability of different diseases, both already-existing and cropping up on the horizon, which can be luckily prevented with Vaccines’ assistance. Pediatric Vaccines form the largest and the most hastily evolving segment as against adult Vaccines, with the trend predicted to stay unaltered in the impending period. The worldwide Vaccine Market is primarily in the paws of such behemoths as Merck & Company, Inc.; Novartis, Pfizer, Inc.; GlaxoSmithKline plc; and Sanofi Pasteur.
The research reports under this Catalogue provide in-depth assessments of the global Vaccine Industry, discussing pressing market issues and statistical figures. The research reports cover the sizing (value/volume) and short-to-long-run forecasts for the overall Vaccine Market and its major segments, and for numerous geographic markets. The listing of M&As among the Vaccine universe participants with new products’ reviews, alongside company profile information can be derived from the research reports too.
Publications found:
977
Sort by:
Global Human Rotavirus Vaccine Market Growth 2025-2031
US$ 3,660.00
The global Human Rotavirus Vaccine market size is predicted to grow from US$ 202 million in 2025 to US$ 248 million in 2031; it is expected to grow at a CAGR of 3.4% from 2025 to 2031. The impact of t...
October 2025
78 pages
Global Virus Like Particles Market Growth 2025-2031
US$ 3,660.00
The global Virus Like Particles market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S....
October 2025
116 pages
Global Measles Vaccine Market Growth 2025-2031
US$ 3,660.00
The global Measles Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S. tarif...
October 2025
119 pages
Global H7N9 Vaccines Market Growth 2025-2031
US$ 3,660.00
The global H7N9 Vaccines market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S. tariff...
October 2025
79 pages
Global Cancer Vaccines Market - 2025 -2033
US$ 4,350.00
Global Cancer Vaccines Market: Industry Outlook The global cancer vaccines market reached US$ 8.82 Billion in 2023, with a rise of US$ 9.27 Billion in 2024 and is expected to reach US$ 14.96 Billion b...
October 2025
180 pages
Global Pediatric Vaccine Market - 2025 -2033
US$ 4,350.00
Pediatric Vaccine Market Size The global pediatric vaccine market size reached US$ 23.25 Billion in 2024 and is expected to reach US$ 38.53 Billion by 2033, growing at a CAGR of 5.8% during the foreca...
October 2025
180 pages
Global Vaccine Adjuvants Market - 2025 -2033
US$ 4,350.00
Vaccine Adjuvants Market Size & Industry Outlook The global vaccine adjuvants market size reached US$ 703.15 Million in 2024 from US$ 661.09 Million in 2023 and is expected to reach US$ 1,280.35 Milli...
October 2025
180 pages
Asia Pacific Cervical Cancer Vaccines Market Size, Share, Trends & Analysis by Vaccine Type (Preventive Vaccine, Therapeutic Vaccine), by Technology (Molecular-based, Vector-based, Others), by Distribution Channel (Hospitals, Clinics, Government Entities) and Region, with Forecasts from 2025 to 2034.
US$ 3,670.00
The Asia Pacific Cervical Cancer Vaccines Market is expected to witness robust growth between 2025 and 2034, fueled by government-led immunization initiatives, rising awareness of human papillomavirus...
September 2025
198 pages
Europe Cervical Cancer Vaccines Market Size, Share, Trends & Analysis by Vaccine Type (Preventive Vaccine, Therapeutic Vaccine), by Technology (Molecular-based, Vector-based, Others), by Distribution Channel (Hospitals, Clinics, Government Entities) and Region, with Forecasts from 2025 to 2034.
US$ 3,670.00
The Europe Cervical Cancer Vaccines Market is projected to experience strong growth from 2025 to 2034, supported by rising awareness of HPV-related diseases, government-led vaccination programs, and c...
September 2025
200 pages
Global Cervical Cancer Vaccines Market Size, Share, Trends & Analysis by Vaccine Type (Preventive Vaccine, Therapeutic Vaccine), by Technology (Molecular-based, Vector-based, Others), by Distribution Channel (Hospitals, Clinics, Government Entities) and Region, with Forecasts from 2025 to 2034.
US$ 3,970.00
The Global Cervical Cancer Vaccines Market is projected to witness robust growth from 2025 to 2034, driven by increasing awareness about cervical cancer prevention, rising government immunization init...
September 2025
216 pages
North America Cervical Cancer Vaccines Market Size, Share, Trends & Analysis by Vaccine Type (Preventive Vaccine, Therapeutic Vaccine), by Technology (Molecular-based, Vector-based, Others), by Distribution Channel (Hospitals, Clinics, Government Entities) and Region, with Forecasts from 2025 to 2034.
US$ 3,670.00
The North America Cervical Cancer Vaccines Market is expected to witness steady growth between 2025 and 2034, driven by strong government vaccination programs, rising public awareness about HPV-relate...
September 2025
205 pages
Dengue Vaccine Market Forecasts to 2032 – Global Analysis By Product (Dengvaxia, Qdenga, and Other Pipeline Candidates), Vaccine Type, Treatment Adjuncts, Route of Administration, Distribution Channel, End User, and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Dengue Vaccine Market is accounted for $489.61 million in 2025 and is expected to reach $1358.91 million by 2032 growing at a CAGR of 15.7% during the forecast...
September 2025
200 pages
Measles, Mumps, Rubella (MMR) Vaccines Market Forecasts to 2032 – Global Analysis By Product (M-M-R II, PRIORIX, Tresivac, M-M-RvaxPro, and Other Product Types), Vaccine Type, Route of Administration, Age Group, Distribution Channel, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Measles, Mumps, Rubella (MMR) Vaccines Market is accounted for $5.73 billion in 2025 and is expected to reach $13.83 billion by 2032 growing at a CAGR of 13.4%...
September 2025
200 pages
Dengue Vaccine Market Size, Share & Trends Analysis Report By Product (Dengvaxia, Qdenga), By End-user (Government & Public Health Agencies, Hospitals & Specialty Clinics), By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
Dengue Vaccine Market The global dengue vaccine market size was estimated at USD 423.18 million in 2024 and is projected to reach USD 1,618.61 million by 2033, growing at a CAGR of 13.73% from 2025 to...
September 2025
150 pages
India Vaccine Market Size, Share & Trends Analysis Report By Indication (Viral Vaccines, Bacterial Vaccines, Cancer Vaccines), By Type, By Route Of Administration (Oral, Parenteral, Nasal), By Age Group, By Distribution Channel, And Segment Forecasts, 2025 - 2033
US$ 3,950.00
India Vaccine Market Size & Trends The India vaccine market was estimated at USD 2.45 billion in 2024 and is projected to reach USD 5.20 billion by 2033, growing at a CAGR of 8.50% from 2025 to 2033....
September 2025
150 pages
India Human Papillomavirus Vaccine Market By Valence (Bivalent, Quadrivalent, Nonvalent, and Others), By Disease Indication (Cervical Cancer, Anal Cancer, Vaginal Cancer, Penile Cancer, Vulvar Cancer, and Others), By Distribution Channel (Hospitals & Clinics, Governmental & Non-Governmental Organizations, Public & Private Alliances, and Others), By Region, Competition, Forecast & Opportunities, 2020-2030F
US$ 3,500.00
Market Overview India Human Papillomavirus Vaccine Market was valued at USD 72.11 Million in 2024 and is expected to reach USD 102.10 Million by 2030, growing with a CAGR of 6.11% in the forecast peri...
September 2025
70 pages
Global Influenza Vaccine Market - 2026-2032
US$ 3,400.00
Global Influenza Vaccine Market reached US$ 8.41 billion in 2024 and is expected to reach US$ 13.75 billion by 2032, growing with a CAGR of 6.50% during the forecast period 2026-2032. The Global Influ...
September 2025
50 pages
Vaccines Market by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, Viral Vector, mRNA), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, Hepatitis, MMR, RSV), Route of Administration (IM, SC, Oral)-Global Forecast to 2030
US$ 2,970.00
The vaccines market is expected to reach 63.66 billion USD in 2030, up from 50.46 billion USD in 2025, growing at a CAGR of 4.8% during the forecast period. Factors such as the high incidence of conta...
September 2025
450 pages
North America Therapeutic Vaccines Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis
US$ 3,450.00
The North America therapeutic vaccines market is projected to grow significantly, reaching approximately USD 1,360,744.52 thousand by 2031, up from USD 565,764.46 thousand in 2024, reflecting a compou...
September 2025
121 pages
Hepatitis A Vaccine Market - 2025-2033
US$ 3,400.00
Hepatitis A Vaccine Marketis is growing with a CAGR of 3.50% during the forecast period 2026-2035. The Hepatitis A Vaccine Market emerges as a key focus in DataM Intelligence latest in-depth analysis,...
September 2025
45 pages
India Coronavirus Vaccine Market By Type (mRNA Based, Non-Replicating Viral Vector Based, Inactivated Vaccine), By Patient Type (Adult, Pediatric), By End User (Hospitals, Clinics, Research Institutes, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F
US$ 3,500.00
Market Overview India Coronavirus Vaccine Market was values at USD 765.18 million in 2024 and is expected to USD 1259.90 Million by 2030, growing with a CAGR of 8.81% in the forecast period. A corona...
August 2025
82 pages
Global Personalized Cancer Vaccines Market - 2025-2033
US$ 3,400.00
Global Personalized Cancer Vaccines Marketis is growing with a CAGR of 11.50% during the forecast period 2026-2035. The Global Personalized Cancer Vaccines Market emerges as a key focus in DataM Intel...
August 2025
61 pages
mRNA Vaccine Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By mRNA Type (Nucleoside-modified mRNA, Unmodified mRNA, Self-Amplifying mRNA), By Application (COVID-19 mRNA Vaccines, Non COVID-19 mRNA Vaccines, Others), Region and Competition, 2020-2030F
US$ 4,500.00
Market Overview Global mRNA Vaccine Market was valued at USD 11.45 billion in 2024 and is expected to reach USD 18.37 Billion by 2030 with a CAGR of 8.34% during the forecast period. The global mRNA...
August 2025
188 pages
Cancer Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Indication Type (Prostate Cancer, Melanoma, Bladder Cancer, Cervical Cancer), By Vaccine Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines), By Technology Type (Recombinant Cancer Vaccines, Whole-Cell Cancer Vaccines, Viral Vector and DNA Cancer Vaccines), By Region and Competition, 2020-2030F
US$ 4,500.00
Market Overview Global Cancer Vaccine Market was valued at USD 8.32 billion in 2024 and is expected to reach USD 14.15 billion in the forecast period with a CAGR of 9.21% through 2030. A cancer vacci...
August 2025
187 pages
Global Influenza Vaccine Market: Analysis By Valency (Quadrivalent & Trivalent), By Vaccine Type (Inactivated And Live Attenuated), By Technology (Egg-based & Cell-based), By Age Group (Adult & Pediatric), By Route Of Administration (Injection & Nasal Spray), By Distribution Channel (Hospitals And Pharmacy, Government And Institutions And Others), By Region Size and Trends with Forecast up to 2030
US$ 2,250.00
The influenza vaccine, often referred to as the flu vaccine, is a critical tool in the field of preventive medicine aimed at reducing the spread and impact of influenza, a contagious respiratory illne...
August 2025
165 pages
Inactivated Vaccines Market - 2025-2032
US$ 3,400.00
Inactivated Vaccines Market reached US$22.60 billion in 2024 and is expected to reach US$34.26 billion by 2032, growing with a CAGR of 4.80% during the forecast period 2026-2032. The Inactivated Vacci...
July 2025
46 pages
Vaccines Market Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Type (Conjugated Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, and Toxoid Vaccines), Indication (HPV, PCV, DTP, Hepatitis, Influenza, Dengue, and Others), Route of Administration (Injection, Oral, and Other), Age Group (Pediatric and Adult), and Geography
US$ 4,450.00
The vaccines market size is expected to grow from US$ 80.45 billion in 2024 to US$ 118.94 billion by 2031; it is projected to register a CAGR of 5.7% during 2025-2031. The growing incidences of infect...
July 2025
226 pages
Live Attenuated Vaccines Market - 2025-2033
US$ 3,400.00
Live Attenuated Vaccines Marketis is growing with a CAGR of 6.60% during the forecast period 2026-2035. The Live Attenuated Vaccines Market emerges as a key focus in DataM Intelligence latest in-depth...
June 2025
50 pages
Toxoid Vaccine Market - 2025-2033
US$ 3,400.00
Toxoid Vaccine Marketis is growing with a CAGR of 5.80% during the forecast period 2026-2035. The Toxoid Vaccine Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where sea...
June 2025
40 pages
Pediatric Vaccine Market - 2025-2033
US$ 3,400.00
Pediatric Vaccine Marketis is growing with a CAGR of 5.80% during the forecast period 2026-2035. The Pediatric Vaccine Market emerges as a key focus in DataM Intelligence latest in-depth analysis, whe...
June 2025
43 pages
Shingles Vaccines Market - 2024-2031
US$ 3,400.00
Shingles Vaccines Marketis is growing with a CAGR of 10.00% during the forecast period 2026-2035. The Shingles Vaccines Market emerges as a key focus in DataM Intelligence latest in-depth analysis, wh...
June 2025
43 pages
Vaccine Storage and Packaging Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Vaccine Storage {Refrigerators, Freezers}, Vaccine Packaging {Cold Boxes, Vials & Ampoules, Corrugated Boxes, Bags, Others}), By Packaging Material (Plastic, Glass, Paper & Paperboard, Others), By End User (Pharma and Biotech Companies, Diagnostic Centers, Clinical Research Organization, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
Market Overview The Global Vaccine Storage and Packaging Market was valued at USD 24.59 Billion in 2024 and is projected to reach USD 46.66 Billion by 2030, registering a CAGR of 11.24%. This market...
May 2025
183 pages
Global Adult Vaccine Market Size study, by Type (Influenza, Pneumococcal, Hepatitis, Zoster, Meningococcal, HPV, DTP, Others), Application (Infectious Diseases, Travel Vaccines, Health Maintenance), and Regional Forecasts 2022-2032
US$ 3,750.00
The Global Adult Vaccine Market is valued approximately at USD 20.51 billion in 2023 and is anticipated to grow with a steady yet compelling growth rate of more than 6.13% over the forecast period 202...
May 2025
285 pages
